Lazebnik L B, Vasil'ev Iu V, Masharova A A, Zelenkin S A, Ianova O B
Eksp Klin Gastroenterol. 2004(6):47-51, 164.
The efficacy of the administration of famotidine, 20 mg BID, at early stages of gastroduodenal reflux disease (GDRD) based on a clinical and endoscopy study and treatment of patients of 0 and 1 degrees on the modified Savary-Miller scale.
基于一项临床和内镜研究以及对改良Savary-Miller量表0度和1度患者的治疗，探讨法莫替丁（20毫克，每日两次）在胃十二指肠反流病（GDRD）早期阶段的疗效。
